Advertisement
The Lancet HIV
Advanced Search

About The Lancet HIV

Register
Subscribe
Submit

About the journal

The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this monthly title is dedicated to publishing original research, evidence-based reviews and insightful features that advocates for change in or illuminates HIV clinical practice. A Fast Track review process is available on request and at the Editor’s discretion, whereby the most topical research papers can be published online within 8 weeks of submission.

Reputation and Impact

The Lancet HIV has an Impact Factor of 14.813® (2019 Journal Citation Reports®, Clarivate Analytics 2020).

Information for Authors

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. We will publish translational, epidemiological, clinical, operational, and implementation studies. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet HIV, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email [email protected]).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations) and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

About our content

Delivering a holistic view of the pandemic, The Lancet HIV publishes original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV. The journal will cover innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of confronting HIV/AIDS worldwide.

Manuscript submission

To submit your manuscript to The Lancet HIV please visit : http://www.editorialmanager.com/thelancethiv

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Peter Hayward, Editor-in-Chief

Peter Hayward was Deputy Editor of The Lancet Infectious Diseases from 2010 and helped to introduce original research and Fast Track peer review to that journal. He is the founding Editor of The Lancet HIV.

Philippa Harris, Deputy Editor

Following a PhD in molecular parasitology at the National Institute of Medical Research, UK, Philippa completed a postdoctoral position at the Albert Einstein College of Medicine, USA. She began her career in scientific publishing with BioMed Central and was the Editor of BMC Infectious Diseases before joining The Lancet HIV as Deputy Editor in January 2018.

Richard Henderson, Senior Editor

Richard joined the publishing sector in 1997 as a journal copy editor. In 2004, he joined the Elsevier Hong Kong office as an editorial project manager and subsequently had a number of different editorial roles at the same office. In 2014, Richard started at The Lancet as a Senior Assistant Editor. He joined The Lancet HIV as Senior Editor in April 2018.

About the Editorial Advisory board

The Editorial Advisory Board consists of key opinion leaders and researchers from around the world who lend their expertise to this journal. If you are interested in finding out more about participating as an Editorial Advisory Board Member, please email [email protected].

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

Cover image volume 7, Issue 11
November 2020
Volume 7, Issue 11